OECD Home › Science and technology › Biotechnology policies › Latest Documents
Water shortage and contamination are cause for increasing concern in many countries. Every year about 13 million people die from waterborne infections; of these, 2 million are children. The majority of deaths occur in developing countries. Howeve...
This summary report discusses some questions raised on : what is a xenogeneic infectious disease event, and what are some of the problems associated with the development of a standardised case definition as well as practical framework for international surveillance.
Regulatory Developments in Xenotransplantation in Hungary.
Regulatory Developments in Xenotransplantation in Germany.
Regulatory Developments in Xenotransplantation in France.
Regulatory Developments in Xenotransplantation in Italy.
This activity seeks to develop, together with the World Health Organisation, the development of standards for surveillance following transplantation and for the import/export of transgenic organs and animals.
Science and technology improves human health but the pressure for faster and larger improvements is increasing in this area. A fundamental starting point for better understanding the impact of innovation on health is the measurement of research and development.
This working paper summarises the information gathered by the OECD Secretariat as part of its work to obtain an accurate assessment of the current state of biotechnology statistics in OECD member and observer countries.